Edgestream Partners L.P. Purchases Shares of 15,912 The Clorox Company (NYSE:CLX)

Edgestream Partners L.P. acquired a new position in shares of The Clorox Company (NYSE:CLX) in the 2nd quarter, HoldingsChannel reports. The fund acquired 15,912 shares of the company’s stock, valued at approximately $2,172,000.

Other large investors also recently made changes to their positions in the company. CIBC Private Wealth Group LLC boosted its position in Clorox by 0.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after purchasing an additional 66 shares during the period. Lindbrook Capital LLC boosted its position in shares of Clorox by 6.2% in the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock worth $181,000 after buying an additional 69 shares during the period. Fiduciary Group LLC grew its stake in shares of Clorox by 0.4% in the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after buying an additional 72 shares in the last quarter. GHP Investment Advisors Inc. raised its holdings in shares of Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock valued at $496,000 after buying an additional 72 shares during the period. Finally, Mesirow Financial Investment Management Inc. lifted its position in Clorox by 5.1% during the 2nd quarter. Mesirow Financial Investment Management Inc. now owns 1,702 shares of the company’s stock worth $233,000 after acquiring an additional 83 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.51% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. DA Davidson reiterated a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. Barclays raised their target price on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research note on Monday, August 5th. Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Finally, Wells Fargo & Company lowered their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. Six investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $143.50.

Clorox Stock Down 0.8 %

CLX stock opened at $163.43 on Thursday. The firm has a market cap of $20.30 billion, a price-to-earnings ratio of 84.68, a PEG ratio of 3.29 and a beta of 0.40. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.09. The firm has a fifty day moving average price of $148.06 and a two-hundred day moving average price of $143.56. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Research analysts predict that The Clorox Company will post 6.63 EPS for the current year.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 14th were given a dividend of $1.22 per share. The ex-dividend date of this dividend was Tuesday, August 13th. This represents a $4.88 dividend on an annualized basis and a yield of 2.99%. This is a positive change from Clorox’s previous quarterly dividend of $1.20. Clorox’s payout ratio is currently 252.85%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.